[Federal Register Volume 60, Number 96 (Thursday, May 18, 1995)]
[Notices]
[Page 26732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12193]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Prospective Grant of Exclusive License: Polysaccharide-Protein 
Conjugates

AGENCY: National Institutes of Health, Public Health Service, DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice is in accordance with 15 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institutes of Health (NIH), 
Department of Health and Human Services, is contemplating the grant of 
an exclusive world-wide license to practice the invention embodied in 
U.S. Patent Number 5,204,098 entitled ``Polysaccharide-Protein 
Conjugates'' and related foreign patent applications to Connaught 
Laboratories, Inc., of Swiftwater, Pennsylvania. The patent rights in 
this invention have been assigned to the United States of America.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. 
It is anticipated that this license will be limited to the field of 
typhoid vaccines and typhoid Vi-protein conjugates for the prevention 
of typhoid fever in humans. This prospective exclusive license may be 
granted unless within 60 days from the date of this published notice, 
NIH receives written evidence and argument that establishes that the 
grant of the license would not be consistent with the requirements of 
35 U.S.C. 209 and 37 CFR 404.7.
    The patent describes conjugates of bacterial capsular 
polysaccharides and carrier proteins, and methods of synthesis, wherein 
the polysaccharide and protein are linked through a thio derivative of 
a carboxyl group found on the polysaccharide. The conjugates are useful 
as vaccines for prevention of disease caused by infection by the 
bacterial species from which the capsular polysaccharide is derived.

ADDRESSES: Requests for a copy of this patent, inquiries, comments and 
other materials relating to the contemplated license should be directed 
to: Robert Benson, Patent Advisor, Office of Technology Transfer, 
National Institutes of Health, 6011 Executive Blvd., Box 13, Rockville, 
MD 20852. Telephone: (301) 496-7056, X267; Facsimile: (301) 402-0220. 
Applications for a license filed in response to this notice will be 
treated as objections to the grant of the contemplated license. Only 
written comments and/or applications for a license which are received 
by NIH on or before July 17, 1995, will be considered.

    Dated: May 5, 1995.
Barbara M. McGarey,
Deputy Director, Office of Technology Transfer.
[FR Doc. 95-12193 Filed 5-17-95; 8:45 am]
BILLING CODE 4140-01-P